Kraig Biocraft Laboratories Announces the Launch of Advanced Gene-Splicing Program and New Transgenics

  • ANN ARBOR, Mich., April 15, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology1, today announced the successful rollout of a next-generation molecular biology and gene-splicing platform.